You asked for ...

AFFORDABLE ICD-10 CODE BOOKS ... we delivered!!! ICD-10-CM ENHANCED FEATURES

2017 ANNUAL

ICD-10-CM The Educational Annotation of ICD-10-CM DISEASES TABULAR LIST & INDEX Codes Effective CRAIG D. PUCKETT October 1, 2016

FEATURES: • • • • • • • •

Channel Publishing, Ltd.

• • • •

DEFINITIONS AND ILLUSTRATIONS ANATOMY & PHYSIOLOGY REVIEWS COLOR HIGHLIGHTING DRG PRINCIPLES AND MCE EDITS AHA CODING CLINIC® REFERENCES OFFICIAL CODING GUIDELINES DIFFERENTIATING TERMS INVALID 3, 4, 5 & 6 DIGIT CODE IDENTIFICATION COMPLETE, OFFICIAL ICD-10-CM TEXT MOST CURRENT VERSION – FY2017 TAB-EDGE DIVIDER PRINTING BEST VALUE OF ANY ICD-10-CM

2017 ANNUAL VERSION • • •

Paperback bound Same content (printing) as SoftCover and Spiral ISBN: 9781933053-76-9

2017 SPIRAL VERSION • • • • •

Spiral coil bound Same content (printing) as SoftCover and Annual ISBN: 9781933053-77-6 With tab-divider set ISBN: 9781933053-78-3

July Sale Price

$54.95 (Reg. $69.95)

July Sale Price

$59.95

BENEFITS FOR CODERS

P P

Anatomy and Physiology Reviews

P

Color Highlighting

P

DRG Principles

P

Identifies codes that are recognized and affected by the DRG Grouper (Red type).

P

Medicare Code Editor Edits

P

Identifies codes that are edit-reviewed for age and sex-related discrepancies and principal diagnosis criteria.

P

AHA Coding Clinic® Reference Notations

P

Identifies AHA Coding Clinic® articles and Q&As (with descriptive title) that have relevant information for certain codes or code categories (Red type).

P

Highlighted Term Differentiation

P

Selected terms within code categories and code titles have been underscored to help coders easily and accurately identify the correct code in the Tabular List.

P

All code categories and codes requiring additional digits in the Tabular List have a dash (-) at the end of the last digit to help coders be aware that additional characters are required for a complete code.

P

All codes requiring one or more “x” placeholder characters to make a complete code have been placed in advance to help coders clearly identify when these “x” placeholders are required.

P

All Excludes-2 listings have a unique graphic “v” and are highlighted in red to more clearly identify those unique excludes notations where a coder may code both conditions, if present.

P

The short descriptions of Excludes 1 and Excludes v are listed on the bottom of each page to help coders learn the difference between the two without referring back to the introduction.

P P

(revised for 2017)

Further use of dashes (-)

Further use of placeholder “x”

P P

Anatomy and physiology reviews that help coders understand the anatomical structures and physiology of the various systems.

P

Color highlighting of key terms (e.g., Excludes 1 & Excludes v) and concepts. Screened areas highlight selected areas (e.g., 7th digit subclassifications).

(Reg. $74.95)

With Tabs

$69.95

P

Excludes v

(Reg. $89.95)

2017 SOFTCOVER VERSION

Medical definitions of diseases written by a coder for coders. Anatomical illustrations with call outs of body parts.

Definitions and Illustrations

P

Excludes 1 and

July Sale Loose-leaf, updateable Excludes v key Price Sturdy, vinyl reusable cover Same content (printing) Red screen bars over the variable 7th digit Highlighted 7th subclassifications in the Tabular List help as Annual and Spiral (Reg. $79.95) digit subclassicoders easily identify those code • Yearly full-text replacement fications Tab Set categories. (Update 30% below new e r a Chapter-by-chapter, section-by-section, book reg. price) Comps and re stair-stepped, colored tab-edge printing Color Tab-Edge (Reg. $17.95) Featu to Any • Optional tab-divider helps coders locate the correct section Priceslisher printing b Pu set (reusable) ($17.95) quickly. • ISBN: 9781933053-79-0 4750 Longley Lane, Suite 110 • Reno, NV 89502-5977 • (775) 825-0880 • Customer Service 1-800-248-2882 • FAX (775) 825-5633 WEB SITE: www.channelpublishing.com • E-MAIL: [email protected] • • •

$64.95 $11.95

P

P

P

P

2016 JULY SALE ORDER FORM

Sale Prices Expire 7/31/16

1. CUSTOMER INFORMATION (Ship books to address below) q Organization or q Individual

ATTN: Name/Title/Dept.

Customer ID #

Shipping Address (Street address required for FedEx delivery)

City

State

2. ORDER INFORMATION Product

C O D E B O O K S

Order Date

E-Mail Address

Zip

Telephone

Fax

2017 July Sale Code Books – Advance Sale Pricing – Payment must accompany order. Quantity

See Web Site for 2016 CODE BOOKS and Complete Product Descriptions

Regular Price

July Sale Price

Total(s)

Exp. 7/31/16

2017 ICD-10-CM, The Educational Annotation of ICD-10-CM Annual Version ICD-10-CM (Paperback) (ISBN: 9781933053-76-9) Spiral Version ICD-10-CM (Spiral coil) (ISBN: 9781933053-77-6) Spiral Version ICD-10-CM with Tabs (Spiral coil) (ISBN: 9781933053-78-3) SoftCover Version ICD-10-CM (Vinyl cover, updateable) (ISBN: 9781933053-79-0) 2017 Update ICD-10-CM (Full text replacement) (ISBN: 9781933053-80-6) 2017 s Tab Set for ICD-10-CM (SoftCover only, reusable) (ITEM: TABCM) Book d o C e able 2017 ICD-10-PCS, The Educational Annotation of ICD-10-PCS Avail 016 Annual Version ICD-10-PCS (Paperback) (ISBN: 9781933053-81-3) 2 Sept. Spiral Version ICD-10-PCS (Spiral coil) (ISBN: 9781933053-82-0) Spiral Version ICD-10-PCS with Tabs (Spiral coil) (ISBN: 9781933053-83-7) SoftCover Version ICD-10-PCS (Vinyl cover, updateable) (ISBN: 9781933053-84-4) 2017 Update ICD-10-PCS (Full text replacement) (ISBN: 9781933053-85-1) Tab Set for ICD-10-PCS (SoftCover only, reusable) (ITEM: TABPCS)

$6995 ea.

$5495 ea.

$74

95

ea.

$5995 ea.

$89

95

ea.

$6995 ea.

$7995 ea. $5595 ea.

$6495 ea. ––

$1795 ea.

$1195 ea.

$5995 ea.

$4595 ea.

$64

95

ea.

$5095 ea.

$79

95

ea.

$6095 ea.

$6995 ea. $4895 ea.

$5595 ea. ––

$1795 ea.

$1195 ea.

(Professional Version – Includes: PowerPoint Slides, Instructor’s Manual, DVD set, Workbook & Code Book) (Individual Version – Includes: DVD set, Workbook & Code Book - CM-12 CEUs, PCS-20 CEUs)

T R A I N I N G

O T H E R

Professional Version – Learning ICD-10-CM (Step 1) (ITEM: SBCM-P) Additional Learning ICD-10-CM Workbook & Book Packages (ITEM: ACM16W) Professional Version – Learning ICD-10-PCS (Step 1) (ITEM: SBPCS-P) Additional Learning ICD-10-PCS Workbook & Book Packages (ITEM: APCS16W) Individual Version – Learning ICD-10-CM (Step 1) (12 CEUs) (ITEM: SBCM-I) Individual Version – Learning ICD-10-PCS (Step 1) (20 CEUs) (ITEM: SBPCS-I) 2016 Mastering ICD-10-CM Exercise Book (Step 2) (ISBN: 9781933053-88-2) 2016 Mastering ICD-10-PCS Exercise Book (Step 2) (ISBN: 9781933053-89-9) 2016 Mastering ICD-10-CM Guidelines Exercise Book (Step 3) (ISBN: 9781933053-90-5) 2016 Mastering ICD-10-PCS Guidelines Exercise Book (Step 3) (ISBN: 9781933053-91-2) The Last Word on ICD-10 (Step 4) (ISBN: 9781933053-61-5) 2017 Clinotes for ICD-10-CM (ISBN: 9781933053-87-5) 2017 Expanded ICD-10-CM Table of Drugs & Chemicals (ISBN: 9781933053-86-8) Acrylic Bookstand q One-piece (ITEM: BSOP) q Two-piece (ITEM: BSTP) CPT® 2016 Standard Edition (ISBN: 9781622022-08-3) CPT® 2016 Professional Edition (ISBN: 9781622022-04-5)

• OUTSIDE CONTINENTAL U.S.: Call for rates and shipping options. U.S. Dollars. • EXPRESS SHIPPING: Call for delivery options and rates.

3. PAYMENT METHOD

q Purchase Order (Attach copy) q Credit Card: MC, VISA, DISC, AMEX

s 2017 Code Book Advance Sale q Check Enclosed Pricing – (Charged date order received) Payment must accompany order.

$29995 ea. $26995 ea. $39995 ea. $35995 ea. –– $5995 ea.

Authorized Cardholder Signature

________________________________________________________________ Billing Address (Street number or PO Box and Zip Code) q Same as shipping

THANK YOU FOR YOUR ORDER

$5995 ea.

––

95

ea.

––

$5995 ea.

––

$6995 ea.

––

$39

95

ea.

$2995 ea.

$39

95

ea.

$34

95

ea.

$2995 ea. ––

$59

Less than $50. . . . . .$7 $50-$99 . . . . . . . . . $12 $100-$199 . . . . . . . $19 $200-$299. . . . . . . .$29 $300+ . . . . . . . . . . .$39

____/____ _______ ___________________________ Sec. Code

$69995 ea. $64995 ea. –– $5595 ea.

July Sale Prices Continental U.S. Expire 7/31/16 Shipping & Handling

__ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __

Exp. Date

$59995 ea. $55995 ea. –– $6595 ea.

$9495 ea.

––

$11995 ea.

––

Product Subtotal Shipping & Handling Nevada Res. Only Add Local Sales Tax

Total Order Amount

MAKE CHECKS PAYABLE AND MAIL TO:

Channel Publishing, Ltd. 4750 Longley Lane, Suite 110 Reno, NV 89502-5977

1-800-248-2882

(775) 825-0880 Fax (775) 825-5633 E-Mail: [email protected] Web Site: www.channelpublishing.com

JS990262

2017 Annual, SoftCover, and Spiral The Educational Annotation of ICD-10-CM •

•

•

This PDF brochure contains 2017 version sample pages, including: Educational Annotations: • Definitions of Code Categories/Titles • Anatomy and Physiology Reviews • Anatomical Illustrations Additional 2017 Educational Annotations Features: • AHA Coding Clinic® Reference Notations • DRG Principles • Medicare Code Edits • Color Highlighting (revised for 2017), including: • Excludes 1 & v • Screened Boxes over 7th Digit Subclassifications • Tab-Edge Printing • Continued Main Terms in Index All the above in addition to our Enhanced Generic features: • Highlighted Term Differentiation • Further Use of Dashes (-) • Further Use of Placeholder “x” • Excludes 1 & v Key • Tab-Edge Printing Key • Clear, Concise Printing TABULAR LIST OF DISEASES – 2017 ICD-10-CM Other specified multiple gestation with two or more AHA Coding Clinic Reference Notations with monochorionic fetuses descriptive titles CC O30.811 Other specified multiple gestation with two or more monochorionic fetuses, first trimester —

O30.81-

O31- Complications specific to multiple gestation AHA 12:4Q:p107 – Fetus A and B same as fetus 1 and 2

[♀, Age/12-55] [Unacceptable PDX] CC O30.812 Highlighted Term Differentiation O30.813 of keyCC word(s) in code titles

Graphic andtwo coloror more Other specified multiple gestation with identification of Excludes 1 monochorionic fetuses, second trimester —

[♀, Age/12-55] [Unacceptable PDX]

and Excludes v

Other specified multiple gestation with two or more monochorionic fetuses, third trimester — [♀, Age/12-55] [Unacceptable PDX]

O30.819 Other specified multiple gestation with two or more trimester — monochorionic fetuses, unspecified Use of demonstrative [♀, Age/12-55] [Unacceptable PDX] type fonts for the letters

“O”two and or “I” more Other specified multiple gestation with monoamniotic fetuses CC O30.821 Other specified multiple gestation with two or more monoamniotic fetuses, first trimester —

O30.82-

[♀, Age/12-55] [Unacceptable PDX]

O

3 4

CC O30.822

Medicare Code Edits Unacceptable PDX, Sex, Age

CC O30.823

I

O

4 1

Other specified multiple gestation with two or more — monoamniotic fetuses, second trimester Further use of dashes (-)

[♀, Age/12-55] [Unacceptable PDX]

to identify codes requiring

Other specified multiple gestationadditional with twocharacters or more monoamniotic fetuses, third trimester — [♀, Age/12-55] [Unacceptable PDX]

O30.829 Other specified multiple gestation with two or more Highlighted Term monoamniotic fetuses, unspecified trimester — Identification of trimesters

[♀, Age/12-55] [Unacceptable PDX]

Excludes 1: = NOT CODED HERE! (Do not code both)

[2017.CM]

Excludes 1 and Excludes v explanations at the bottom of all Tabular List pages

Excludes v: delayed delivery of second twin, triplet, etc. (O63.2) malpresentation of one fetus or more (O32.9) placental transfusion syndromes (O43.0-)

One of the following 7th characters is to be assigned to each code under category O31. 7th character 0 is for single gestations and multiple gestations where the fetus is unspecified. 7th characters 1 through 9 are for cases of multiple gestations to identify the fetus for which the code applies. The appropriate code from category O30, Multiple gestation, must also be assigned when assigning a code from category O31 that has a 7th character of 1 through 9. 0 Not applicable or unspecified 1 Fetus 1 Color shading of 2 Fetus 2 notations to guide coders 3 Fetus 3 in the use of 7th character 4 Fetus 4 extensions 5 Fetus 5 9 Other fetus O31.0- Papyraceous fetus Fetus compressus O31.00x- Papyraceous fetus, unspecified trimester — [♀, Age/12-55] O31.01x- Papyraceous fetus, first trimester — [♀, Age/12-55] O31.02x- Papyraceous fetus, second trimester — [♀, Age/12-55] O31.03x- Papyraceous fetus, third trimester — [♀, Age/12-55] Further use of O31.1- Continuing pregnancyplaceholder after spontaneous abortion of one fetus “x” or more O31.10x- Continuing pregnancy after spontaneous abortion of one fetus or more, unspecified trimester — [♀, Age/12-55] Excludesv: = Not Included Here

OFFICIAL CODING GUIDELINES – 2017 ICD-10-CM

CHAPTER 10 – RESPIRATORY SYSTEM Section I. C. 10. d.

CHAPTER 10 – RESPIRATORY SYSTEM Section I. C. 10. 10. Chapter 10: Diseases of the Respiratory System (J00-J99) a.

2)

Chronic Obstructive Pulmonary Disease [COPD] and Asthma 1)

b.

Acute exacerbation of chronic obstructive bronchitis and asthma The codes in categories J44 and J45 distinguish between uncomplicated cases and those in acute exacerbation. An acute exacerbation is a worsening or a decompensation of a chronic condition. An acute exacerbation is not equivalent to an infection superimposed on a chronic condition, though an exacerbation may be triggered by an infection.

11. Chapter 11: Diseases of the Digestive System (K00-K94)

Acute Respiratory Failure 1)

Acute respiratory failure as principal diagnosis A code from subcategory J96.0, Acute respiratory failure, or subcategory J96.2, Acute and chronic respiratory failure, may be assigned as a principal diagnosis when it is the condition established after study to be chiefly responsible for occasioning the admission to the hospital, and the selection is supported by the Alphabetic Index and Tabular List. However, chapterspecific coding guidelines (such as obstetrics, poisoning, HIV, newborn) that provide sequencing direction take precedence.

2)

Acute respiratory failure as secondary diagnosis Respiratory failure may be listed as a secondary diagnosis if it occurs after admission, or if it is present on admission, but does not meet the definition of principal diagnosis.

3)

Sequencing of acute respiratory failure and another acute condition When a patient is admitted with respiratory failure and another acute condition, (e.g., myocardial infarction, cerebrovascular accident, aspiration pneumonia), the principal diagnosis will not be the same in every situation. This applies whether the other acute condition is a respiratory or nonrespiratory condition. Selection of the principal diagnosis will be dependent on the circumstances of admission. If both the respiratory failure and the other acute condition are equally responsible for occasioning the admission to the hospital, and there are no chapter-specific sequencing rules, the guideline regarding two or more diagnoses that equally meet the definition for principal diagnosis (Section II, C.) may be applied in these situations.

Reserved for future guideline expansion

12. Chapter 12: Diseases of the Skin and Subcutaneous Tissue (L00-L99) a.

Pressure ulcer stage codes 1)

Influenza due to certain identified influenza viruses Code only confirmed cases of influenza due to certain identified influenza viruses (category J09), and due to other identified influenza virus (category J10). This is an exception to the hospital inpatient guideline Section II, H. (Uncertain Diagnosis). In this context, “confirmation” does not require documentation of positive laboratory testing specific for avian or other novel influenza A or other identified influenza virus. However, coding should be based on the provider’s diagnostic statement that the patient has avian influenza, or other novel influenza A, for category J09, or has another particular identified strain of influenza, such as H1N1 or H3N2, but not identified as novel or variant, for category J10.

Assign as many codes from category L89 as needed to identify all the pressure ulcers the patient has, if applicable. 2)

Unstageable pressure ulcers Assignment of the code for unstageable pressure ulcer (L89.--0) should be based on the clinical documentation. These codes are used for pressure ulcers whose stage cannot be clinically determined (e.g., the ulcer is covered by eschar or has been treated with a skin or muscle graft) and pressure ulcers that are documented as deep tissue injury but not documented as due to trauma. This code should not be confused with the codes for unspecified stage (L89.--9). When there is no documentation regarding the stage of the pressure ulcer, assign the appropriate code for unspecified stage (L89.--9).

3)

Documented pressure ulcer stage Assignment of the pressure ulcer stage code should be guided by clinical documentation of the stage or documentation of the terms found in the Alphabetic Index. For clinical terms describing the stage that are not found in the Alphabetic Index, and there is no documentation of the stage, the provider should be queried.

4)

Patients admitted with pressure ulcers documented as healed No code is assigned if the documentation states that the pressure ulcer is completely healed.

5)

Patients admitted with pressure ulcers documented as healing Pressure ulcers described as healing should be assigned the appropriate pressure ulcer stage code based on the documentation in the medical record. If the documentation does not provide information about the stage of the healing pressure ulcer, assign the appropriate code for unspecified stage.

If the provider records “suspected” or “possible” or “probable” avian influenza, or novel influenza, or other identified influenza, then the appropriate influenza code from category J11, Influenza due to unidentified influenza virus, should be assigned. A code from category J09, Influenza due to certain identified influenza viruses, should not be assigned nor should a code from category J10, Influenza due to other identified influenza virus. d.

Pressure ulcer stages Codes from category L89, Pressure ulcer, are combination codes that identify the site of the pressure ulcer as well as the stage of the ulcer. The ICD-10-CM classifies pressure ulcer stages based on severity, which is designated by stages 1-4, unspecified stage and unstageable.

If the documentation is not clear as to whether acute respiratory failure and another condition are equally responsible for occasioning the admission, query the provider for clarification. c.

Ventilator associated Pneumonia Develops after Admission A patient may be admitted with one type of pneumonia (e.g., code J13, Pneumonia due to Streptococcus pneumonia) and subsequently develop VAP. In this instance, the principal diagnosis would be the appropriate code from categories J12-J18 for the pneumonia diagnosed at the time of admission. Code J95.851, Ventilator associated pneumonia, would be assigned as an additional diagnosis when the provider has also documented the presence of ventilator associated pneumonia.

If the documentation is unclear as to whether the patient has a current (new) pressure ulcer or if the patient is being treated for a healing pressure ulcer, query the provider.

Ventilator associated Pneumonia 6) 1)

Documentation of Ventilator associated Pneumonia As with all procedural or postprocedural complications, code assignment is based on the provider’s documentation of the relationship between the condition and the procedure. Code J95.851, Ventilator associated pneumonia, should be assigned only when the provider has documented ventilator associated pneumonia (VAP). An additional code to identify the organism (e.g., Pseudomonas aeruginosa, code B96.5) should also be assigned. Do not assign an additional code from categories J12-J18 to identify the type of pneumonia. Code J95.851 should not be assigned for cases where the patient has pneumonia and is on a mechanical ventilator and the provider has not specifically stated that the pneumonia is ventilator-associated pneumonia. If the documentation is unclear as to whether the patient has a pneumonia that is a complication attributable to the mechanical ventilator, query the provider.

CG-12

Patient admitted with pressure ulcer evolving into another stage during the admission If a patient is admitted with a pressure ulcer at one stage and it progresses to a higher stage, assign the code for the highest stage reported for that site.

© 2016 Channel Publishing, Ltd.

G U I D E L I N E S

[2017.CM]

[2017.CM]

INDEX TO DISEASES – 2017 ICD-10-CM

Failure

Exposure (to) (see also Contact, with) T 75.89 — Failure, failed — continued continued gain weight (child over 28 days old) R62.51 venereal disease Z20.2 adult R62.7 viral disease NEC Z20.828 newborn P92.6 Faber’s syndrome (achlorhydric anemia) war Z65.5 genital response (male) F52.21 D50.9 water pollution Z77.111 female F52.22 Fabry(-Anderson) disease E75.21 Exsanguination — see Hemorrhage heart (acute) (senile) (sudden) I50.9 Faciocephalalgia, autonomic (see also Exstrophy with Neuropathy, peripheral, autonomic) G90.09 abdominal contents Q45.8 acute pulmonary edema — see Failure, Factor(s) bladder Q64.10 ventricular, left psychic, associated with diseases classified cloacal Q64.12 decompensation — see Failure, heart, Duplication elsewhere F54 specified type NEC Q64.19 congestive of all terms and code psychological supravesical fissure Q64.11 numbers at “— continued” dilatation — see Disease, heart affecting physical conditions F54 column headers and printed in Extensive — see condition arteriosclerotic I70.90 or behavioral color Extra — see also Accessory biventricular I50.9 affecting general medical condition F54 marker chromosomes (normal individual) combined left-right sided I50.9 associated with disorders or diseases Q92.61 compensated I50.9 classified elsewhere F54 in abnormal individual Q92.62 complicating Fahr disease (of brain) G23.8 rib Q76.6 anesthesia (general) (local) or other Fahr Volhard disease (of kidney) I12cervical Q76.5 sedation Failure, failed Extrasystoles (supraventricular) I49.49 in labor and delivery O74.2 abortion — see Abortion, attempted atrial I49.1 in pregnancy O29.12aortic (valve) I35.8 auricular I49.1 postpartum, puerperal O89.1 rheumatic I06.8 junctional I49.2 delivery (cesarean) (instrumental) O75.4 attempted abortion — see Abortion, attempted ventricular I49.3 congestive (compensated) (decompensated) biventricular I50.9 Extrauterine gestation or pregnancy — I50.9 bone marrow — see Anemia, aplastic with rheumatic fever (conditions in I00) see Pregnancy, by site cardiac — see Failure, heart active I01.8 Extravasation of demonstrative cardiorenal (chronic)Use I50.9 inactive or quiescent (with chorea) blood R58 type fonts for the letters “O” hypertensive I13.2 I09.81 chyle into mesentery I89.8 and “I” heart) R09.2 cardiorespiratory (see also Failure, newborn P29.0 pelvicalyceal N13.8 cardiovascular (chronic) — see Failure, heart rheumatic (chronic) (inactive) (with chorea) pyelosinus N13.8 cerebrovascular I67.9 I09.81 urine (from ureter) R39.0 cervical dilatation in labor O62.0 active or acute I01.8 vesicant agent circulation, circulatory (peripheral) R57.9 with chorea I02.0 antineoplastic chemotherapy T80.810 newborn P29.89 decompensated I50.9 other agent NEC T80.818 compensation — see Disease, heart degenerative — see Degeneration, Extremity — see condition, limb compliance with medical treatment or regimen Extrophy — see Exstrophy myocardial — see Noncompliance Extroversion diastolic (congestive) I50.30 congestive — see Failure, heart, congestive bladder Q64.19 acute (congestive) I50.31 dental implant (endosseous) M27.69 uterus N81.4 and (on) chronic (congestive) I50.33 due to complicating delivery O71.2 chronic (congestive) I50.32 failure of dental prosthesis M27.63 postpartal (old) N81.4 and (on) acute (congestive) I50.33 lack of attached gingiva M27.62 Extruded tooth (teeth) M26.34 combined with systolic (congestive) I50.40 occlusal trauma (poor prosthetic design) Extrusion acute (congestive) I50.41 M27.62 breast implant (prosthetic) T85.42 and (on) chronic (congestive) I50.43 parafunctional habits M27.62 eye implant (globe) (ball) T85.328 chronic (congestive) I50.42 periodontal infection (peri-implantitis) intervertebral disc — see Displacement, and (on) acute (congestive) I50.43 M27.62 intervertebral disc due to presence of cardiac prosthesis poor oral hygiene M27.62 ocular lens implant (prosthetic) — see I97.13osseointegration M27.61 Complications, intraocular lens following cardiac surgery I97.13due to vitreous — see Prolapse, vitreous high output NOS I50.9 complications of systemic disease Exudate hypertensive — see Hypertension, heart M27.61 pleural — see Effusion, pleura left (ventricular) — see Failure, ventricular, poor bone quality M27.61 retina H35.89 left iatrogenic M27.61 Exudative — see condition low output (syndrome) NOS I50.9 post-osseointegration Eye, eyeball, eyelid — see condition newborn P29.0 biological M27.62 Eyestrain — see Disturbance, vision, subjective organic — see Disease, heart due to complications of systemic disease Eyeworm disease of Africa B74.3 peripartum O90.3 M27.62 postprocedural I97.13iatrogenic M27.62 rheumatic (chronic) (inactive) I09.9 mechanical M27.63 right (ventricular) (secondary to left heart pre-integration M27.61 failure) — see Failure, heart, congestive pre-osseointegration M27.61 systolic (congestive) I50.20 specified NEC M27.69 acute (congestive) I50.21 descent of head (at term) of pregnancy and (on) chronic (congestive) I50.23 (mother) O32.4 chronic (congestive) I50.22 Clear, concise, endosseous dental implant — see Failure, and (on) acute (congestive) I50.23 sharply-printed text dental implant combined with diastolic (congestive) engagement of head (term of pregnancy) I50.40 (mother) O32.4 acute (congestive) I50.41 erection (penile) (see also Dysfunction, sexual, and (on) chronic (congestive) I50.43 male, erectile) N52.9 chronic (congestive) I50.42 nonorgqanic F52.21 and (on) acute (congestive) I50.43 examination(s), anxiety concerning Z55.2 thyrotoxic (see also Thyrotoxicosis) E05.90 expansion terminal respiratory units (newborn) [I43] (primary) P28.0 with thyroid storm E05.91 [I43] forceps NOS (with subsequent cesarean valvular — see Endocarditis delivery) O66.5

© 2016 Channel Publishing, Ltd.

F

161

D I S E A S E I N D E X

D I S E A S E I N D E X

Gout, chronic (see also Gout, gouty) M1A.9 (follows M08) — continued secondary NEC M1A.40 (follows M08) ankle M1A.47- (follows M08) elbow M1A.42- (follows M08) foot joint M1A.47- (follows M08) hand joint M1A.44- (follows M08) hip M1A.45- (follows M08) knee M1A.46- (follows M08) multiple site M1A.49 (follows M08) shoulder M1A.41- (follows M08) vertebrae M1A.48 (follows M08) wrist M1A.43- (follows M08) syphilitic (see also subcategory M14.8-) A52.77 tophi M1A.9 (follows M08) Gout, gouty (acute) (attack) (flare) (see also Gout, chronic) M10.9 drug-induced M10.20 ankle M10.27elbow M10.22foot joint M10.27hand joint M10.24hip M10.25knee M10.26multiple site M10.29 shoulder M10.21vertebrae M10.28 wrist M10.23idiopathic M10.00 ankle M10.07elbow M10.02foot joint M10.07hand joint M10.04hip M10.05knee M10.06multiple site M10.09 shoulder M10.01vertebrae M10.08 wrist M10.03in (due to) renal impairment M10.30 ankle M10.37elbow M10.32foot joint M10.37hand joint M10.34hip M10.35knee M10.36multiple site M10.39 shoulder M10.31vertebrae M10.38 wrist M10.33lead-induced M10.10 ankle M10.17Easy to follow elbow M10.12sub-term indention foot joint M10.17hand joint M10.14- outline and line wraps hip M10.15knee M10.16multiple site M10.19 shoulder M10.11vertebrae M10.18 wrist M10.13primary — see Gout, idiopathic saturnine — see Gout, lead-induced secondary NEC M10.40 ankle M10.47elbow M10.42foot joint M10.47hand joint M10.44hip M10.45knee M10.46multiple site M10.49 shoulder M10.41vertebrae M10.48 wrist M10.43syphilitic (see also subcategory M14.8-) A52.77 tophi — see Gout, chronic

INDEX TO DISEASES – 2017 ICD-10-CM Gower’s muscular dystrophy G71.0 syndrome (vasovagal attack) R55 Gradenigo’s syndrome — see Otitis, media, suppurative, acute Graefe’s disease — see Strabismus, paralytic, ophthalmoplegia, progressive (follows ...) disease D89.813 Graft-versus-host helps easily find the acutecoders D89.810 mid-code alpha character code acute on chronic D89.812 in theD89.811 Tabular List chronic Grain mite (itch) B88.0 Grainhandler’s disease or lung J67.8 Grand mal — see Epilepsy, generalized, specified NEC Grand multipara status only (not pregnant) Z64.1 pregnant — see Pregnancy, complicated by, grand multiparity Granite worker’s lung J62.8 Granular — see also condition inflammation, pharynx J31.2 kidney (contracting) — see Sclerosis, renal liver K74.69 Granulation tissue (abnormal) (excessive) L92.9 postmastoidectomy cavity — see Complications, postmastoidectomy, granulation Granulocytopenia (primary) (malignant) — see Agranulocytosis Granuloma L92.9 abdomen K66.8 from residual foreign body L92.3 pyogenicum L98.0 actinic L57.5 annulare (perforating) L92.0 apical K04.5 aural — see Otitis, externa, specified NEC beryllium (skin) L92.3 bone eosinophilic C96.6 from residual foreign body — see Osteomyelitis, specified type NEC lung C96.6 brain (any site) G06.0 schistosomiasis B65.9 [G07] canaliculus lacrimalis — see Granuloma, lacrimal candidal (cutaneous) B37.2 cerebral (any site) G06.0 coccidioidal (primary) (progressive) B38.7 lung B38.1 meninges B38.4 colon K63.89 conjunctiva H11.22dental K04.5 ear, middle — see Cholesteatoma eosinophilic C96.6 bone C96.6 lung C96.6 oral mucosa K13.4 skin L92.2 eyelid H01.8 facial(e) L92.2 foreign body (in soft tissue) NEC M60.20 ankle M60.27foot M60.27forearm M60.23hand M60.24in operation wound — see Foreign body, accidentally left during a procedure lower leg M60.26pelvic region M60.25shoulder region M60.21skin L92.3 specified site NEC M60.28 subcutaneous tissue L92.3

186

[2017.CM]

Granuloma L92.9 — continued foreign body (in soft tissue) NEC M60.20 — continued thigh M60.25upper arm M60.22gangraenescens M31.2 genito-inguinale A58 giant cell (central) (reparative) (jaw) M27.1 gingiva (peripheral) K06.8 gland (lymph) I88.8 hepatic NEC K75.3 in (due to) berylliosis J63.2 [K77] sarcoidosis D86.89 Hodgkin C81.9 ileum K63.89 infectious B99.9 specified NEC B99.8 inguinale (Donovan) (venereal) A58 intestine NEC K63.89 intracranial (any site) G06.0 intraspinal (any part) G06.1 iridocyclitis — see Iridocyclitis, chronic jaw (bone) (central) M27.1 reparative giant cell M27.1 kidney (see also Infection, kidney) N15.8 lacrimal H04.81larynx J38.7 lethal midline (faciale(e)) M31.2 liver NEC — see Granuloma, hepatic lung (infectious) — see also Fibrosis, lung coccidioidal B38.1 eosinophilic C96.6 Majocchi’s B35.8 malignant (facial(e)) M31.2 mandible (central) M27.1 midline (lethal) M31.2 monilial (cutaneous) B37.2 nasal sinus — see Sinusitis operation wound T81.89 foreign body — see Foreign body, accidentally left during a procedure stitch T81.89 talc — see Foreign body, accidentally left during a procedure oral mucosa K13.4 orbit, orbital H05.11paracoccidioidal B41.8 penis, venereal A58 periapical K04.5 peritoneum K66.8 due to ova of helminths NOS (see also Helminthiasis) B83.9 [K67] postmastoidectomy cavity — see Complications, postmastoidectomy, recurrent cholesteatoma prostate N42.89 pudendi (ulcerating) A58 pulp, internal (tooth) K03.3 pyogenic, pyogenicum (of) (skin) L98.0 gingiva K06.8 maxillary alveolar ridge K04.5 oral mucosa K13.4 rectum K62.89 reticulohistiocytic D76.3 rubrum nasi L74.8 Schistosoma — see Schistosomiasis septic (skin) L98.0 silica (skin) L92.3 sinus (accessory) (infective) (nasal) — see Sinusitis skin L92.9 from residual foreign body L92.3 pyogenicum L98.0 spine syphilitic (epidural) A52.19 tuberculous A18.01 stitch (postoperative) T81.89

© 2016 Channel Publishing, Ltd.

Gout

ign Ben

Ca I n si tu

Neoplasm, neoplastic - continued alveolar - continued ................ C03.9 C79.89 D00.03 D10.39 D37.09 D49.0

ICD-10-CM Table of Neoplasms

ridge or process ...................... carcinoma............................ lower .............................. upper .............................. lower .................................. mucosa................................ lower .............................. upper .............................. upper .................................. Where such descriptors are not present, the remainder of the sulcus ...................................... Index should be consulted where guidance is given to the alveolus ...................................... appropriate column for each morphological (histological) variety lower ...................................... listed; e.g., Mesonephroma — see Neoplasm, malignant; upper ...................................... Embryoma — see also Neoplasm, uncertain behavior; Disease, ampulla of Vater ........................ Bowen’s — see Neoplasm, skin, in situ. However, the guidance in ankle NEC.................................... the Index can be overridden if one of the descriptors mentioned anorectum, anorectal above is present; e.g., malignant adenoma of colon is coded to (junction) ............................ C18.9 and not to D12.6 as the adjective “malignant” overrides antecubital fossa or space .......... the Index entry “Adenoma — see also Neoplasm, benign.” antrum (Highmore) (maxillary).......................... Codes listed with a dash -, following the code have a required pyloric...................................... additional character for laterality. The tabular list must be tympanicum ............................ reviewed for the complete code. anus, anal .................................. canal........................................ cloacogenic zone .................... Neoplasm, neoplastic ........ C80.1 C79.9 D09.9 D36.9 D48.9 D49.9 margin — see also abdomen, abdominal.................. C76.2 C79.8- D09.8 D36.7 D48.7 D49.89 cavity ...................................... C76.2 C79.8- D09.8 D36.7 D48.7 D49.89 Neoplasm, anus, skin...... organ ...................................... C76.2 C79.8- D09.8 D36.7 D48.7 D49.89 overlapping lesion with viscera .................................... C76.2 C79.8- D09.8 D36.7 D48.7 D49.89 rectosigmoid junction wall — see also Neoplasm, or rectum ........................ skin.......................................... abdomen, wall, skin ...... C44.509 C79.2- D04.5 D23.5 D48.5 D49.2 basal cell carcinoma............ connective tissue ................ C49.4 C79.8- — D21.4 D48.1 D49.2 specified type NEC .............. skin .................................... C44.509 — — — — — squamous cell basal cell carcinoma........ C44.519 — — — — — carcinoma .................. specified type NEC .......... C44.599 — — — — — sphincter.................................. squamous cell aorta (thoracic) .......................... carcinoma .............. C44.529 — — — — — abdominal .............................. abdominopelvic .......................... C76.8 C79.8- — D36.7 D48.7 D49.89 aortic body .................................. accessory sinus — see aponeurosis ................................ Neoplasm, sinus palmar .................................... acoustic nerve.............................. C72.4- C79.49 — D33.3 D43.3 D49.7 plantar .................................... adenoid (pharynx) (tissue).......... C11.1 C79.89 D00.08 D10.6 D37.05 D49.0 appendix .................................... adipose tissue — see also Highlighted arachnoid .................................... Neoplasm, connective Malignant and Benign cerebral .................................. tissue .................................. C49.4 C79.89 — D21.9 D48.1 D49.2 Neoplasm columns to provide an spinal ...................................... adnexa (uterine) ........................ C57.4 C79.89 D07.39 D28.7 D39.8 D49.5 visual separation easy-to-follow areola.......................................... adrenal........................................ C74.9- C79.7- D09.3 D35.0- D44.1- D49.7 arm NEC ...................................... capsule .................................... C74.9- C79.7- D09.3 D35.0- D44.1- D49.7 artery — see Neoplasm, cortex ...................................... C74.0- C79.7- D09.3 D35.0- D44.1- D49.7 gland ...................................... C74.9- C79.7- D09.3 D35.0- D44.1- D49.7 connective tissue medulla .................................. C74.1- C79.7- D09.3 D35.0- D44.1- D49.7 aryepiglottic fold ........................ ala nasi (external) — see also hypopharyngeal aspect .......... laryngeal aspect...................... Neoplasm, skin, nose.......... C44.301 C79.2 D04.39 D23.39 D48.5 D49.2 marginal zone ........................ alimentary canal or tract NEC .... C26.9 C78.80 D01.9 D13.9 D37.9 D49.0 arytenoid (cartilage) .................. alveolar ...................................... C03.9 C79.89 D00.03 D10.39 D37.09 D49.0 fold — see Neoplasm, mucosa .................................... C03.9 C79.89 D00.03 D10.39 D37.09 D49.0 lower .................................. C03.1 C79.89 D00.03 D10.39 D37.09 D49.0 aryepiglottic upper .................................. C03.0 C79.89 D00.03 D10.39 D37.09 D49.0 associated with transplanted organ .................................. atlas ............................................ atrium, cardiac ............................ The list below gives the code numbers for neoplasms by anatomical site. For each site there are six possible code numbers according to whether the neoplasm in question is malignant, benign, in situ, of uncertain behavior, or of unspecified nature. The description of the neoplasm will often indicate which of the six columns is appropriate; e.g., malignant melanoma of skin, benign fibroadenoma of breast, carcinoma in situ of cervix uteri.

© 2016 Channel Publishing, Ltd.

ary

Neoplasm Table

Neoplasm Mal igna Prim n ary t Mal Sec ignant ond

Unc Beh ertain avio r Uns pec Beh ified avio r

ign Ben

Ca I n si tu

ary

Neoplasm Table

Mal igna Prim n ary t Mal Sec ignant ond

INDEX TO DISEASES – 2017 ICD-10-CM

Unc Beh ertain avio r Uns pec Beh ified avio r

[2017.CM]

269

C41.1 C03.9 C03.1 C03.0 C41.1 C03.9 C03.1 C03.0 C41.0 C06.1 C03.9 C03.1 C03.0 C24.1 C76.5-

C79.51 C79.8C79.8C79.8C79.51 C79.89 C79.89 C79.89 C79.51 C79.89 C79.89 C79.89 C79.89 C78.89 C79.89

— — — — — D00.03 D00.03 D00.03 — D00.02 D00.03 D00.03 D00.03 D01.5 D04.7-

D16.5— — — D16.5D10.39 D10.39 D10.39 D16.4D10.39 D10.39 D10.39 D10.39 D13.5 D36.7

D48.0 — — — D48.0 D37.09 D37.09 D37.09 D48.0 D37.09 D37.09 D37.09 D37.09 D37.6 D48.7

D49.2 — — — D49.2 T D49.0 A D49.0 B D49.0 L D49.2 E D49.0 D49.0 D49.0 D49.0 D49.0 D49.89

C21.8 C78.5 D01.3 D12.9 D37.8 D49.0 C76.4- C79.89 D04.6- D36.7 D48.7 D49.89 C31.0 C16.3 C30.1 C21.0 C21.1 C21.2

C78.39 C78.89 C78.39 C78.5 C78.5 C78.5

D02.3 D00.2 D02.3 D01.3 D01.3 D01.3

D14.0 D13.1 D14.0 D12.9 D12.9 D12.9

D38.5 D37.1 D38.5 D37.8 D37.8 D37.8

N E O P L A S M

D49.1 D49.0 D49.1 D49.0 D49.0 D49.0

C44.500 C79.2

D04.5 D23.5 D48.5 D49.2

C21.8 C44.500 C44.510 C44.590

— C79.2 — —

— — — — D04.5 D23.5 D48.5 D49.2 — — — — — — — —

C44.520 C21.1 C49.3 C49.4 C75.5 C49.9 C49.1C49.2C18.1 C70.9 C70.0 C70.1 C50.0C76.4-

— C78.5 C79.89 C79.89 C79.89 C79.89 C79.89 C79.89 C78.5 C79.49 C79.32 C79.49 C79.81 C79.89

— D01.3 — — — — — — D01.0 — — — D05.D04.6-

— D12.9 D21.3 D21.4 D35.6 D21.9 D21.1D21.2D12.1 D32.9 D32.0 D32.1 D24.D36.7

— D37.8 D48.1 D48.1 D44.7 D48.1 D48.1 D48.1 D37.3 D42.9 D42.0 D42.1 D48.6D48.7

— D49.0 D49.2 D49.2 D49.7 D49.2 D49.2 D49.2 D49.0 D49.7 D49.7 D49.7 D49.3 D49.89

C13.1 C13.1 C32.1 C13.1 C32.3

C79.89 C79.89 C78.39 C79.89 C78.39

D00.08 D00.08 D02.0 D00.08 D02.0

D10.7 D10.7 D14.1 D10.7 D14.1

D37.05 D37.05 D38.0 D37.05 D38.0

D49.0 D49.0 D49.1 D49.0 D49.1

C80.2 C41.2 C38.0

— C79.51 C79.89

— — —

— — — D16.6 D48.0 D49.2 D15.1 D48.7 D49.89

© 2016 Channel Publishing, Ltd.

G

14-hydroxydihydromorphinone ................ 1-propanol .......................... 2,4,5-T (trichlorophenoxyacetic acid) .... 2,4-D (dichlorophenoxyacetic acid) ............ 2,4-toluene diisocyanate .... 2-propanol .......................... ABOB .................................. Abrine ................................ Abrus (seed)........................ Absinthe .............................. beverage ........................ Acaricide.............................. Acebutolol .......................... Acecarbromal ...................... Aceclidine ............................ Acedapsone ........................ Acefylline piperazine .......... Acemorphan........................ Acenocoumarin.................... Acenocoumarol.................... Acepifylline.......................... Acepromazine .................... Acesulfamethoxypyridazine Acetal .................................. Acetaldehyde (vapor).......... liquid .............................. P-Acetamidophenol ............ Acetaminophen .................. Acetaminosalol.................... Acetanilide .......................... Acetarsol.............................. Acetazolamide .................... Acetiamine .......................... Acetic acid.................................. with sodium acetate (ointment) .......... ester (solvent) (vapor) irrigating solution ...... medicinal (lotion) ...... anhydride........................ ether (vapor) .................. Acetohexamide.................... Acetohydroxamic acid.......... Acetomenaphthone ............ Acetomorphine.................... Acetone (oils) ...................... chlorinated...................... vapor .............................. Acetonitrile.......................... Acetophenazine .................. Acetophenetedin ................ Acetophenone...................... Acetorphine ........................ Acetosulfone (sodium) ........ Acetrizoate (sodium) .......... Acetrizoic acid...................... Acetyl bromide .......................... chloride ..........................

T40.2x1- T40.2x2T51.3x1- T51.3x2T60.1x1- T60.1x2T60.3x1T65.0x1T51.2x1T37.5x1T62.2x1T62.2x1T51.0x1T51.0x1T60.8x1T44.7x1T42.6x1T44.1x1T37.0x1T48.6x1T40.2x1T45.511T45.511T48.6x1T43.3x1T37.0x1T52.8x1T52.8x1T65.891T39.1x1T39.1x1T39.1x1T39.1x1T37.3x1T50.2x1T45.2x1-

T60.3x2T65.0x2T51.2x2T37.5x2T62.2x2T62.2x2T51.0x2T51.0x2T60.8x2T44.7x2T42.6x2T44.1x2T37.0x2T48.6x2T40.2x2T45.512T45.512T48.6x2T43.3x2T37.0x2T52.8x2T52.8x2T65.892T39.1x2T39.1x2T39.1x2T39.1x2T37.3x2T50.2x2T45.2x2-

T54.2x1- T54.2x2T49.3x1T52.8x1T50.3x1T49.2x1T65.891T52.8x1T38.3x1T50.991T45.7x1T40.1x1T52.4x1T52.4x1T52.4x1T52.8x1T43.3x1T39.1x1T52.4x1T40.2x1T37.1x1T50.8x1T50.8x1-

T49.3x2T52.8x2T50.3x2T49.2x2T65.892T52.8x2T38.3x2T50.992T45.7x2T40.1x2T52.4x2T52.4x2T52.4x2T52.8x2T43.3x2T39.1x2T52.4x2T40.2x2T37.1x2T50.8x2T50.8x2-

T53.6x1- T53.6x2T53.6x1- T53.6x2-

Table of Drugs & Chemicals

P

O

I

S

O

N

Acetylcarbromal .................. T42.6x1- T42.6x2T40.2x3- T40.2x4- T40.2x5- T40.2x6- Acetylcholine chloride .......................... T44.1x1- T44.1x2T51.3x3- T51.3x4- — — derivative ...................... T44.1x1- T44.1x2Acetylcysteine ...................... T48.4x1- T48.4x2T60.1x3- T60.1x4- — — Acetyldigitoxin .................... T46.0x1- T46.0x2Acetyldigoxin ...................... T46.0x1- T46.0x2T60.3x3- T60.3x4- — — Acetyldihydrocodeine .......... T40.2x1- T40.2x2T65.0x3- T65.0x4- — — Acetyldihydrocodeinone ...... T40.2x1- T40.2x2T51.2x3- T51.2x4— — Clearly identified T37.5x3- Poisoning T37.5x4- T37.5x5columns T37.5x6- Acetylene (gas).................... T59.891- T59.892dichloride ........................ T53.6x1- T53.6x2T62.2x3- T62.2x4- — — incomplete combustion of T58.11x- T58.12xT62.2x3- T62.2x4- — — industrial ........................ T59.891- T59.892T51.0x3- T51.0x4- — — tetrachloride.................... T53.6x1- T53.6x2T51.0x3- T51.0x4- — — vapor .......................... T53.6x1- T53.6x2T60.8x3- T60.8x4- — — T44.7x3- T44.7x4- T44.7x5- T44.7x6- Acetylpheneturide .............. T42.6x1- T42.6x2T42.6x3- T42.6x4- T42.6x5- T42.6x6- Acetylphenylhydrazine ........ T39.8x1- T39.8x2Clearly identifiedT39.012.... T39.011T44.1x3- T44.1x4- T44.1x5- T44.1x6- Acetylsalicylic acid (salts) Adverse Effect columns enteric coated.................. T39.011- T39.012T37.0x3- T37.0x4- T37.0x5- T37.0x6T48.6x3- T48.6x4- T48.6x5- T48.6x6- Acetylsulfamethoxypyridazine ............................ T37.0x1- T37.0x2T40.2x3- T40.2x4- T40.2x5- T40.2x6T45.513- T45.514- T45.515- T45.516- Achromycin.......................... T36.4x1- T36.4x2ophthalmic preparation .. T49.5x1- T49.5x2T45.513- T45.514- T45.515- T45.516topical NEC...................... T49.0x1- T49.0x2T48.6x3- T48.6x4- T48.6x5- T48.6x6T43.3x3- T43.3x4- T43.3x5- T43.3x6- Aciclovir .............................. T37.5x1- T37.5x2T37.0x3- T37.0x4- T37.0x5- T37.0x6- Acid (corrosive) NEC............ T54.2x1- T54.2x2Acidifying agent NEC .......... T50.901- T50.902T52.8x3- T52.8x4- — — Acipimox.............................. T46.6x1- T46.6x2T52.8x3- T52.8x4- — — Acitretin .............................. T50.991- T50.992T65.893- T65.894- — — T39.1x3- T39.1x4- T39.1x5- T39.1x6- Aclarubicin .......................... T45.1x1- T45.1x2T39.1x3- T39.1x4- T39.1x5- T39.1x6- Aclatonium napadisilate .... T48.1x1- T48.1x2T39.1x3- T39.1x4- T39.1x5- T39.1x6- Aconite (wild)...................... T46.991- T46.992T39.1x3- T39.1x4- T39.1x5- T39.1x6- Aconitine ............................ T46.991- T46.992T37.3x3- T37.3x4- T37.3x5- T37.3x6- Aconitum ferox.................... T46.991- T46.992Clearly identified T50.2x3- T50.2x4- T50.2x5T50.2x6- Acridine .............................. T65.6x1- T65.6x2Accidental (Unintentional) vapor .............................. T59.891- T59.892T45.2x3- T45.2x4- T45.2x5- T45.2x6columns Acriflavine .......................... T37.91x- T37.92xAcriflavinium chloride ........ T49.0x1- T49.0x2T54.2x3- T54.2x4- — — Acrinol ................................ T49.0x1- T49.0x2T49.3x3- T49.3x4- T49.3x5- T49.3x6- Acrisorcin ............................ T49.0x1- T49.0x2Acrivastine .......................... T45.0x1- T45.0x2T52.8x3- T52.8x4- — — T50.3x3- T50.3x4- T50.3x5- T50.3x6- Acrolein (gas)...................... T59.891- T59.892liquid .............................. T54.1x1- T54.1x2T49.2x3- T49.2x4- T49.2x5- T49.2x6Acrylamide .......................... T65.891- T65.892T65.893- T65.894- — — Acrylic resin ........................ T49.3x1- T49.3x2T52.8x3- T52.8x4- — — T38.3x3- T38.3x4- T38.3x5- T38.3x6- Acrylonitrile ........................ T65.891- T65.892T50.993- T50.994- T50.995- T50.996- Actaea spicata .................... T62.2x1- T62.2x2berry................................ T62.1x1- T62.1x2T45.7x3- T45.7x4- T45.7x5- T45.7x6Acterol ................................ T37.3x1- T37.3x2T40.1x3- T40.1x4- — — ACTH .................................. T38.811- T38.812T52.4x3- T52.4x4- — — Actinomycin C ...................... T45.1x1- T45.1x2T52.4x3- T52.4x4- — — Actinomycin D .................... T45.1x1- T45.1x2T52.4x3- T52.4x4- — — Activated charcoal – T52.8x3- T52.8x4- — — T43.3x3- T43.3x4- T43.3x5- T43.3x6see also Charcoal, T39.1x3- T39.1x4- T39.1x5- T39.1x6medicinal .................... T47.6x1- T47.6x2T52.4x3- T52.4x4- — — Acyclovir .............................. T37.5x1- T37.5x2T40.2x3- T40.2x4- — — Adenine .............................. T45.2x1- T45.2x2T37.1x3- T37.1x4- T37.1x5- T37.1x6arabinoside .................... T37.5x1- T37.5x2T50.8x3- T50.8x4- T50.8x5- T50.8x6- Adenosine (phosphate) ...... T46.2x1- T46.2x2T50.8x3- T50.8x4- T50.8x5- T50.8x6- ADH .................................... T38.891- T38.892Adhesive NEC ...................... T65.891- T65.892T53.6x3- T53.6x4- — — Adicillin .............................. T36.0x1- T36.0x2T53.6x3- T53.6x4- — —

407

I

N

G

SelfHarm Accidental (IntenUndeter(Unintentional) tional) Assault mined

ing

N

dos

I

der

N

ing

O

SelfHarm Accidental (IntenUndeter(Unintentional) tional) Assault mined

dos

S

der

I

Drugs & Chemicals

Un

Chemicals

O

Un

Drugs &

P

Ad v Eff erse ect

Table of

INDEX TO DISEASES – 2017 ICD-10-CM

Ad v Eff erse ect

[2017.CM]

D T42.6x3- T42.6x4- T42.6x5- T42.6x6- R U G T44.1x3- T44.1x4- T44.1x5- T44.1x6- S T44.1x3- T44.1x4- T44.1x5- T44.1x6T48.4x3- T48.4x4- T48.4x5- T48.4x6- & T46.0x3- T46.0x4- T46.0x5- T46.0x6- C T46.0x3- T46.0x4- T46.0x5- T46.0x6- H E T40.2x3- T40.2x4- — — M I T40.2x3- T40.2x4- — — C T59.893- T59.894- — — A T53.6x3- T53.6x4- — — L S T58.13x- T58.14x- — — T59.893- T59.894- — — T53.6x3- T53.6x4- — — T53.6x3- T53.6x4- — — T42.6x3- T42.6x4- T42.6x5- T42.6x6T39.8x3- T39.8x4- T39.8x5- T39.8x6T39.013- T39.014- T39.015- T39.016T39.013- T39.014- T39.015- T39.016T37.0x3T36.4x3T49.5x3T49.0x3T37.5x3T54.2x3T50.903T46.6x3T50.993T45.1x3T48.1x3T46.993T46.993T46.993T65.6x3T59.893T37.93xT49.0x3T49.0x3T49.0x3T45.0x3T59.893T54.1x3T65.893T49.3x3T65.893T62.2x3T62.1x3T37.3x3T38.813T45.1x3T45.1x3-

T37.0x4T36.4x4T49.5x4T49.0x4T37.5x4T54.2x4T50.904T46.6x4T50.994T45.1x4T48.1x4T46.994T46.994T46.994T65.6x4T59.894T37.94xT49.0x4T49.0x4T49.0x4T45.0x4T59.894T54.1x4T65.894T49.3x4T65.894T62.2x4T62.1x4T37.3x4T38.814T45.1x4T45.1x4-

T37.0x5T36.4x5T49.5x5T49.0x5T37.5x5— T50.905T46.6x5T50.995T45.1x5T48.1x5T46.995T46.995T46.995— — T37.95xT49.0x5T49.0x5T49.0x5T45.0x5— — — T49.3x5— — — T37.3x5T38.815T45.1x5T45.1x5-

T37.0x6T36.4x6T49.5x6T49.0x6T37.5x6 — T50.906T46.6x6T50.996T45.1x6T48.1x6T46.996T46.996T46.996— — T37.96xT49.0x6T49.0x6T49.0x6T45.0x6— — — T49.3x6— — — T37.3x6T38.816T45.1x6T45.1x6-

T47.6x3T37.5x3T45.2x3T37.5x3T46.2x3T38.893T65.893T36.0x3-

T47.6x4T37.5x4T45.2x4T37.5x4T46.2x4T38.894T65.894T36.0x4-

T47.6x5T37.5x5T45.2x5T37.5x5T46.2x5T38.895— T36.0x5-

T47.6x6T37.5x6T45.2x6T37.5x6T46.2x6T38.896— T36.0x6-

TABULAR LIST OF DISEASES – 2017 ICD-10-CM B08- Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified Excludes 1:

B09 Unspecified viral infection characterized by skin and mucous membrane lesions Viral enanthema NOS Viral exanthema NOS

vesicular stomatitis virus disease (A93.8)

B08.0- Other orthopoxvirus infections Excludes : monkeypox (B04)

B08.01- Cowpox and vaccinia not from vaccine B08.010 Cowpox — A viral infectious disease of cattle that is caused by the

B08.011

Other human herpesviruses (B10) B10- Other human herpesviruses

Excludes : cytomegalovirus (B25.9) Epstein-Barr virus (B27.0-) herpes NOS (B00.9) herpes simplex (B00-) herpes zoster (B02-) human herpesvirus NOS (B00-) human herpesvirus 1 and 2 (B00-) human herpesvirus 3 (B01.-, B02.-) human herpesvirus 4 (B27.0-) human herpesvirus 5 (B25-) varicella (B01-) zoster (B02-)

Cowpox virus, which infects man through skin contact and is characterized by vesicopustular lesions on the hands, face, and/or other cutaneous sites. Vaccinia not from vaccine — An infection that results from the accidentally induced vaccinia virus and is not from an intentional medical care vaccination. Excludes 1: vaccinia (from vaccination) (generalized) (T88.1)

B08.02 Orf virus disease

Contagious pustular dermatitis Ecthyma contagiosum

B08.03 Pseudocowpox [milker’s node] — A viral disease characterized by

A 7 7 I

A 8 5

B10.0- Other human herpesvirus encephalitis — Inflammation of the brain

circumscribed nodules on the hands of workers who milk cows infected with cowpox.

caused by a human herpesvirus infection. Excludes : herpes encephalitis NOS (B00.4) herpes simplex encephalitis (B00.4) human herpesvirus encephalitis (B00.4) simian B herpes virus encephalitis (B00.4)

B08.04 Paravaccinia, unspecified B08.09 Other orthopoxvirus infections Orthopoxvirus infection NOS

B08.1

Molluscum contagiosum — An infectious viral disease caused by a Poxvirus,

MCC B10.01

and characterized by discrete pearly skin papules containing caseous matter. B08.2- Exanthema subitum [sixth disease] — A sudden, mild viral illness caused by the human herpesvirus that is characterized by a few days of fever, followed by a faint pink rash, usually seen on the trunk. Roseola infantum B08.20 Exanthema subitum [sixth disease], unspecified — [Age/0-17] Roseola infantum, unspecified

MCC B10.09

Human herpesvirus 7 encephalitis

Human herpesvirus 8 infection Kaposi’s sarcoma-associated herpesvirus infection

Viral hepatitis (B15-B19)

Roseola infantum due to human herpesvirus 6

B08.22 Exanthema subitum [sixth disease] due to human herpesvirus 7 — [Age/0-17] Roseola infantum due to human herpesvirus 7

B08.4

B08.5

Erythema infectiosum [fifth disease] — A contagious viral infectious disease that is caused by Parvovirus B19 and is characterized by a rose-colored macular rash, occurring mainly in children. Enteroviral vesicular stomatitis with exanthem — An infectious viral disease caused by Coxsackie A virus, and characterized by vesicular eruption of hands, feet, and mouth. NOTE: Foot and mouth disease (B08.8) is a separate and different infection. Hand, foot and mouth disease

Excludes 1: sequelae of viral hepatitis (B94.2) Excludes : cytomegaloviral hepatitis (B25.1) herpesviral [herpes simplex] hepatitis (B00.81) B15- Acute hepatitis A — The initial/first stage (within the first 6 months after someone is exposed) of an infection and inflammation of the liver caused by the hepatitis A virus, that is characterized by jaundice, anorexia, nausea, dark urine, pale stool, and vomiting. MCC B15.0 CC B15.9

Herpangina

B08.6- Parapoxvirus infections B08.60 Parapoxvirus infection, unspecified B08.61 Bovine stomatitis — A cutaneous infection in humans caused by contact with cattle infected with bovine papular stomatitis. B08.62 Sealpox — A cutaneous infection in humans caused by contact with seals and sea lions infected with the sealpox virus.

Hepatitis A (acute) (viral) NOS exposed) of an infection and inflammation of the liver caused by the hepatitis B virus, that is characterized by jaundice, urticarial skin lesions, and arthritis. MCC B16.0 CC B16.1 MCC B16.2 CC B16.9

Acute hepatitis B with delta-agent with hepatic coma Acute hepatitis B with delta-agent without hepatic coma Acute hepatitis B without delta-agent with hepatic coma Acute hepatitis B without delta-agent and without hepatic coma Hepatitis B (acute) (viral) NOS

B08.69 Other parapoxvirus infections B08.7- Yatapoxvirus infections B08.70 Yatapoxvirus infection, unspecified CC B08.71 Tanapox virus disease — A viral infection caused by the Tanapox virus

B17- Other acute viral hepatitis — The initial/first stage (within the first 6 months after someone is exposed) of an infection and inflammation of the liver caused by a hepatitis virus. CC B17.0

Acute delta-(super) infection of hepatitis B carrier B17.1- Acute hepatitis C CC B17.10 Acute hepatitis C without hepatic coma

that is characterized by fever, headaches, and often itching at the cutaneous lesion sites. B08.72 Yaba pox virus disease — A viral infection caused by the Yaba monkey tumor virus that is characterized by a tumor or nodule containing histiocytes. Yaba monkey tumor disease

Enteroviral lymphonodular pharyngitis Foot-and-mouth disease — An infectious viral disease caused by picornavirus affecting cattle and rarely humans. Poxvirus NEC

Hepatitis A with hepatic coma Hepatitis A without hepatic coma

B16- Acute hepatitis B — The initial/first stage (within the first 6 months after someone is

Enteroviral vesicular pharyngitis

B08.79 Other yatapoxvirus infections B08.8 Other specified viral infections characterized by skin and mucous membrane lesions

Human herpesvirus 6 encephalitis Other human herpesvirus encephalitis

B10.8- Other human herpesvirus infection B10.81 Human herpesvirus 6 infection B10.82 Human herpesvirus 7 infection B10.89 Other human herpesvirus infection

B08.21 Exanthema subitum [sixth disease] due to human herpesvirus 6 — [Age/0-17]

CC B08.3

Acute hepatitis C NOS MCC B17.11 CC B17.8

Acute hepatitis C with hepatic coma Acute hepatitis E Other specified acute viral hepatitis

CC B17.9

Acute viral hepatitis, unspecified

CC B17.2

Hepatitis non-A non-B (acute) (viral) NEC Acute hepatitis NOS

B18- Chronic viral hepatitis — The second, long-term illness stage of an infection and inflammation of the liver caused by a hepatitis virus. CC B18.0 CC B18.1

Chronic viral hepatitis B with delta-agent Chronic viral hepatitis B without delta-agent Chronic (viral) hepatitis B

Excludes 1: = NOT CODED HERE! (Do not code both)

[2017.CM]

536

Excludes : = Not Included Here

[2017.CM]

CHAPTER 2 – NEOPLASMS – 2017 ICD-10-CM

C16- Malignant neoplasm of stomach — Any new and abnormal growth of the

CC C16.5

Malignant neoplasm of lesser curvature of stomach,

stomach in which tissue growth is uncontrolled and has the properties of anaplasia, invasion, unspecified — The smaller, innermost curved vertical portion from the and metastases. esophagus to the duodenum. Use additional code to identify: Malignant neoplasm of lesser curvature of stomach, not classifiable Alcohol abuse and dependence (F10.-) to C16.1-C16.4 Excludes : malignant carcinoid tumor of the stomach (C7A.092) CC C16.6 Malignant neoplasm of greater curvature of stomach, ANATOMY OF THE STOMACH — The stomach, located in the upper abdomen, is a pouchunspecified — The larger, outermost curved vertical portion from the like organ of the alimentary tract connecting with the esophagus in the proximal esophagus to the duodenum. (upper) portion and the duodenum in the distal (lower) portion and is about 10 to 12 Malignant neoplasm of greater curvature of stomach, not inches (25 to 30 cm) long. The cardia lies at the opening of the esophagus at the fundus classifiable to C16.0-C16.4 of the stomach. The fundus is the upper ballooned area of the stomach. The body is the CC C16.8 Malignant neoplasm of overlapping sites of stomach main part of the stomach and is located between the fundus and the pyloric antrum and the duodenum. When empty, the mucous membrane on the interior surface forms CC C16.9 Malignant neoplasm of stomach, unspecified longitudinal folds, called rugae. There are three mucosal glands which secrete digestive Gastric cancer NOS juices and mucus. These are the gastric glands, which are located throughout the body C17Malignant neoplasm of small intestine — Any new and abnormal growth of of the stomach; the cardiac glands, which are found near the esophageal opening; and the small intestine, including duodenum, in which tissue growth is uncontrolled and has the the pyloric glands, which are located in the pyloric (distal) region. There are three properties of anaplasia, invasion, and metastases. layers of smooth muscle, and a serosal covering of visceral peritoneum. The vagus Excludes 1: malignant carcinoid tumors of the small intestine (C7A.01) nerve stimulates the gastric glands. The stomach has a rich arterial blood supply ANATOMY OF THE SMALL INTESTINE — The small intestine is the tubular organ of the through the celiac artery. The venous blood is drained into the hepatic portal system. alimentary tract between the stomach and large intestine and is about 16 to 20 feet (5 PHYSIOLOGY OF THE STOMACH — The stomach functions to receive food from the to 6 m) long, and has 3 parts: Duodenum, jejunum, and ileum. The duodenum is the esophagus, mixes it with the gastric juice, initiates the digestion of proteins with pepsin, first portion about 10 inches (25 cm) long connected at its proximal end to the stomach. carries on a limited amount of absorption, and moves food into the small intestine by The jejunum is the middle, approximately two-fifths, portion. The ileum is the distal peristaltic muscle action. The gastric glands produce mucous, digestive enzymes portion which connects with the large intestine. Both the jejunum and ileum are (pepsin), hydrochloric acid, and an intrinsic factor, forming the gastric juice. The mucous suspended from the posterior abdominal wall by the mesentery. is thought to help prevent the pepsin and hydrochloric acid from digesting the stomach PHYSIOLOGY OF THE SMALL INTESTINE — The small intestine functions to absorb water surface. The stomach may absorb small quantities of water, glucose, certain salts, and and the nutrients produced through digestion. The food is passed through the small alcohol. The parasympathetic vagus nerve stimulates the gastric glands to secrete large intestine by the contraction of its circular smooth muscle layer, called peristalsis. The amounts of gastric juice which, in turn, releases gastrin, a hormone that causes the duodenum releases several enzymes and mixes the pancreatic and bile juices with food gastric glands to increase their secretory activity. from the stomach. The jejunum and ileum continue mixing and absorbing until the remaining substances pass into the large intestine.

CC C16.1 CC C16.2 CC C16.3

CC C16.4

Malignant neoplasm of cardia — The opening and junction of the

CC C17.0

Malignant neoplasm of duodenum — The most proximal portion

CC C17.1

Malignant neoplasm of jejunum — The middle portion which is larger

CC C17.2

Malignant neoplasm of ileum — The distal portion connecting with the

connected with the stomach.

stomach from the esophagus. Malignant neoplasm of cardiac orifice Malignant neoplasm of cardio-esophageal junction Malignant neoplasm of esophagus and stomach Malignant neoplasm of gastro-esophageal junction Malignant neoplasm of fundus of stomach — The ballooned upper end of the stomach lying above a transverse line drawn from the cardia. Malignant neoplasm of body of stomach — The main pouch-like portion. Malignant neoplasm of pyloric antrum — That portion between the body and the pylorus. Malignant neoplasm of gastric antrum Malignant neoplasm of pylorus — The opening between the pyloric antrum and the duodenum. Malignant neoplasm of prepylorus Malignant neoplasm of pyloric canal

Excludes 1: = NOT CODED HERE! (Do not code both)

I

C 1 5

Pylorus

CC C16.0

C 1 3

in diameter than the ileum. cecum. Excludes 1: CC C17.3

malignant neoplasm of ileocecal valve (C18.0)

Meckel’s diverticulum, malignant — A sacculation or appendage of the ileum, specified as malignant. Excludes 1: Meckel’s diverticulum, congenital (Q43.0)

CC C17.8 CC C17.9

555

Malignant neoplasm of overlapping sites of small intestine Malignant neoplasm of small intestine, unspecified

Excludes : = Not Included Here

[2017.CM]

C63.7

CHAPTER 2 – NEOPLASMS – 2017 ICD-10-CM C66- Malignant neoplasm of ureter — Any new and abnormal growth of the ureter

Malignant neoplasm of other specified male genital organs — [♂]

Malignant neoplasm of seminal vesicle — The tube-like glands attached to the vas deferens near the base of the bladder which secrete a slightly alkaline fluid rich in nutrients and prostaglandins. Malignant neoplasm of tunica vaginalis — The serous membrane covering the front and sides of the testis and epididymis.

C63.8

C63.9

Malignant neoplasm of overlapping sites of male genital organs — [♂]

Primary malignant neoplasm of two or more contiguous sites of male genital organs whose point of origin cannot be determined Malignant neoplasm of male genital organ, unspecified — [♂] Malignant neoplasm of male genitourinary tract NOS

(the musculomembranous tubes which convey urine from the kidneys to the bladder) in which the tissue growth is uncontrolled and has the properties of anaplasia, invasion, and metastases. Excludes 1: malignant neoplasm of ureteric orifice of bladder (C67.6)

Malignant neoplasm of right ureter Malignant neoplasm of left ureter CC C66.9 Malignant neoplasm of unspecified ureter C67- Malignant neoplasm of bladder — Any new and abnormal growth of the bladder

Malignant neoplasms of urinary tract (C64-C68) C64- Malignant neoplasm of kidney, except renal pelvis — Any new and abnormal growth of the kidney in which the tissue growth is uncontrolled and has the properties of anaplasia, invasion, and metastases. Excludes 1: malignant carcinoid tumor of the kidney (C7A.093) malignant neoplasm of renal calyces (C65.-) malignant neoplasm of renal pelvis (C65.-) ANATOMY OF THE KIDNEYS — The kidneys are reddish-brown, bean-shaped organs about 4.7 inches (12 cm) long, 2.3 inches (6 cm) wide, and 1.2 inches (3 cm) thick, and are located on either side of the vertebral column in the retroperitoneal space. The kidneys are supplied with arterial blood from the renal arteries which branch off from the aorta, and are drained by the renal veins which connect with the inferior vena cava. The renal pelvis is the funnel-shaped urinary collecting system of the kidney at the upper end of a ureter. PHYSIOLOGY OF THE KIDNEYS — The kidneys function to remove metabolic wastes from the blood by transferring them into the urine. They also regulate red blood cell production, blood pressure, calcium absorption, and the pH level of the blood.

CC C66.1 CC C66.2

in which the tissue growth is uncontrolled and has the properties of anaplasia, invasion, and metastases. ANATOMY OF THE BLADDER — The urinary bladder is a hollow, collapsible musculomembranous organ, and is located within the pelvic cavity, behind the symphysis pubis. In the male, it lies against the rectum, and in the female it lies against the vagina and uterus. When filled it may contain 17 fluid ounces (500 ml) of urine and pushes upward indenting the abdominal cavity. The trigone area is the floor of the bladder formed by three points, the two ureteral orifices and the urethral orifice. The dome is the expandable superior surface of the bladder. The bladder neck is that area surrounding the urethral orifice. The ureteric orifice is that area surrounding the ureteral openings. The urachus in the adult forms the middle umbilical ligament of the bladder. PHYSIOLOGY OF THE BLADDER — The urinary bladder functions as a reservoir for the urine produced by the kidneys until the individual expels the urine (micturition). Micturition occurs when the bladder becomes distended with urine and stretch receptor nerves signal the micturition center in the sacral spinal cord. Parasympathetic nerve impulses start rhythmically contracting the bladder and the individual senses an urgency to urinate. Following the midbrain decision to urinate, the external urethral sphincter is relaxed, and urination begins as the bladder muscle contracts.

I

C 6 3

C67.0

Malignant neoplasm of trigone of bladder — The area of the

C67.1

Malignant neoplasm of dome of bladder — The expandable superior

C67.2 C67.3 C67.4 C67.5

Malignant neoplasm of lateral wall of bladder Malignant neoplasm of anterior wall of bladder Malignant neoplasm of posterior wall of bladder Malignant neoplasm of bladder neck — The outlet area of bladder

bladder floor formed by the ureteral orifices and the urethral orifice. surface of the bladder. CC C64.1

Malignant neoplasm of right kidney, except renal pelvis Malignant neoplasm of left kidney, except renal pelvis CC C64.9 Malignant neoplasm of unspecified kidney, except renal pelvis C65- Malignant neoplasm of renal pelvis — Any new and abnormal growth of the CC C64.2

kidney pelvis in which the tissue growth is uncontrolled and has the properties of anaplasia, invasion, and metastases. Includes: Malignant neoplasm of pelviureteric junction — The funnel-shaped urine collecting system of the kidneys. Malignant neoplasm of renal calyces — The minor subdivisions of the renal pelvis. CC C65.1 CC C65.2 CC C65.9

Malignant neoplasm of right renal pelvis Malignant neoplasm of left renal pelvis Malignant neoplasm of unspecified renal pelvis

Excludes 1: = NOT CODED HERE! (Do not code both)

571

C 6 0

C67.6 C67.7 C67.8 C67.9

surrounding the urethral orifice. Malignant neoplasm of internal urethral orifice Malignant neoplasm of ureteric orifice — The opening of a ureter into the bladder. Malignant neoplasm of urachus — The fetal urinary tract that in the adult forms the middle umbilical ligament of the bladder.

Malignant neoplasm of overlapping sites of bladder Malignant neoplasm of bladder, unspecified

Excludes : = Not Included Here

[2017.CM]

CHAPTER 11 – DISEASES OF THE DIGESTIVE SYSTEM – 2017 ICD-10-CM K22.5

Diseases of esophagus, stomach and duodenum (K20-K31) Excludes : hiatus hernia (K44.-)

K20- Esophagitis — Inflammation of the esophagus.

Use additional code to identify: Alcohol abuse and dependence (F10.-) Excludes 1: erosion of esophagus (K22.1-) esophagitis with gastro-esophageal reflux disease (K21.0) reflux esophagitis (K21.0) ulcerative esophagitis (K22.1-) Excludes : eosinophilic gastritis or gastroenteritis (K52.81) K20.0 Eosinophilic esophagitis — A condition involving eosinophil accumulation in the tissues lining the esophagus and characterized by severe inflammation that affects the ability to swallow.

K20.8

Other esophagitis

K20.9

Esophagitis, unspecified

Abscess of esophagus — A localized collection of pus in the esophagus formed by the disintegration of tissues.

creating a herniated sac or pouch of tissue. Esophageal pouch, acquired — A pocket-like space or sac in the esophagus. Excludes 1: diverticulum of esophagus (congenital) (Q39.6) MCC K22.6 Gastro-esophageal laceration-hemorrhage syndrome — The slit-like bleeding lacerations of the esophagogastric junction following several days of severe vomiting. Mallory-Weiss syndrome K22.7- Barrett’s esophagus — A metaplastic disorder of the lining of the lower esophagus caused by gastroesophageal reflux damage to the esophageal mucosa that is characterized by esophageal lining cells changing from squamous cells to goblet cells (usually found in the small intestine). Barrett’s disease Barrett’s syndrome Excludes 1: Barrett’s ulcer (K22.1) malignant neoplasm of esophagus (C15.-)

K22.70 Barrett’s esophagus without dysplasia Barrett’s esophagus NOS

Esophagitis NOS

K22.71- Barrett’s esophagus with dysplasia — A form with the

K21- Gastro-esophageal reflux disease — A disease caused by a reflux of acid and

development and presence of abnormal, potentially cancerous cells.

pepsin from the stomach. Excludes 1: newborn esophageal reflux (P78.83)

K21.0

Gastro-esophageal reflux disease with esophagitis — A form with inflammation of the esophagus. Reflux esophagitis

K21.9

K22.8

K22.710 Barrett’s esophagus with low grade dysplasia K22.711 Barrett’s esophagus with high grade dysplasia K22.719 Barrett’s esophagus with dysplasia, unspecified Other specified diseases of esophagus Hemorrhage of esophagus NOS Excludes : esophageal varices (I85.-) Paterson-Kelly syndrome (D50.1)

Gastro-esophageal reflux disease without esophagitis Esophageal reflux NOS

K22- Other diseases of esophagus

Excludes : esophageal varices (I85.-) K22.0 Achalasia of cardia — Failure to relax the smooth muscle fibers of the esophagogastric sphincter due to degeneration of the ganglion cells in the wall of the esophagus. Achalasia NOS Cardiospasm Excludes 1: congenital cardiospasm (Q39.5) K22.1- Ulcer of esophagus — An open sore of the lining of the esophagus. Barrett’s ulcer — See Ulcer of Esophagus above. Erosion of esophagus — The eating-away of the lining of the esophagus. Fungal ulcer of esophagus — A form caused by necrotic fungal infection. Peptic ulcer of esophagus — A form caused by the action of the acid gastric juice. Ulcer of esophagus due to ingestion of chemicals Ulcer of esophagus due to ingestion of drugs and medicaments Ulcerative esophagitis — See Ulcer of Esophagus above. Code first poisoning due to drug or toxin, if applicable (T36-T65 with fifth or sixth character 1-4 or 6) Use additional code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5) Excludes 1: Barrett’s esophagus (K22.7-) CC K22.10

Diverticulum of esophagus, acquired — A defect in the esophagus

K23

K22.9 Disease of esophagus, unspecified Disorders of esophagus in diseases classified elsewhere — [Not Allowed as PDX] Code first underlying disease, such as: Congenital syphilis (A50.5) Excludes 1: late syphilis (A52.79) megaesophagus due to Chagas’ disease (B57.31) tuberculosis (A18.83)

K25- Gastric ulcer — An inflammatory, necrotic, sloughing defect (open sore) in the gastric mucosa. Includes:

Erosion (acute) of stomach Pylorus ulcer (peptic) — A form located in the pyloric antrum of the stomach. Stomach ulcer (peptic) — A form located in any portion of the stomach. Use additional code to identify: Alcohol abuse and dependence (F10.-) Excludes 1: acute gastritis (K29.0-) peptic ulcer NOS (K27.-)

I

K 2 5

Ulcer of esophagus without bleeding Ulcer of esophagus NOS

MCC K22.11

K22.2

MCC K22.3

K22.4

Ulcer of esophagus with bleeding — A form with the escape of

blood from the ulcer site. Excludes : bleeding esophageal varices (I85.01, I85.11) Esophageal obstruction — Blocking or clogging of the esophagus. Compression of esophagus — External pressure on the esophagus causing narrowing of the esophageal lumen. Constriction of esophagus — The narrowing of the esophagus. Stenosis of esophagus — The decrease in caliber of the esophagus. Stricture of esophagus — The narrowing of the esophagus. Excludes 1: congenital stenosis or stricture of esophagus (Q39.3) Perforation of esophagus — A hole or opening through the esophageal wall. Rupture of esophagus — Forcible tearing or disruption through the esophageal wall. Excludes 1: traumatic perforation of (thoracic) esophagus (S27.8-) Dyskinesia of esophagus — Impairment of the muscular control of the esophagus. Corkscrew esophagus — Esophageal spasm giving the appearance of a corkscrew. Diffuse esophageal spasm — The strong, painful, incoordinated, nonpropulsive contractions of the esophagus. Spasm of esophagus — The painful contractions of the esophagus. Excludes 1: cardiospasm (K22.0)

MCC K25.0

Acute gastric ulcer with hemorrhage — A form marked by sudden,

MCC K25.1

Acute gastric ulcer with perforation — A form marked by sudden,

severe onset with hemorrhage at the site of the ulcer. severe onset with the creation of a hole through the stomach wall into the abdominal cavity. MCC K25.2

Acute gastric ulcer with both hemorrhage and perforation — A form marked by sudden, severe onset with hemorrhage and a hole through the stomach wall into the abdominal cavity.

MCC K25.4

CC K25.3

Acute gastric ulcer without hemorrhage or perforation Chronic or unspecified gastric ulcer with hemorrhage — A form

MCC K25.5

Chronic or unspecified gastric ulcer with perforation — A form

marked by slow, persistent progression with hemorrhage at the site of the ulcer. marked by slow, persistent progression with the creation of a hole through the stomach wall into the abdominal cavity. MCC K25.6

Chronic or unspecified gastric ulcer with both hemorrhage and perforation — A form marked by slow, persistent progression with hemorrhage and a hole through the stomach wall into the abdominal cavity.

K25.7 Excludes 1: = NOT CODED HERE! (Do not code both)

K 2 0

779

Chronic gastric ulcer without hemorrhage or perforation

Excludes : = Not Included Here

TABULAR LIST OF DISEASES – 2017 ICD-10-CM O35- Maternal care for known or suspected fetal abnormality and damage

O36- Maternal care for other fetal problems AHA 12:4Q:p107 – Fetus A and B same as fetus 1 and 2 Includes: The listed conditions in the fetus as a reason for hospitalization or other obstetric care of the mother, or for termination of pregnancy Excludes 1: encounter for suspected maternal and fetal conditions ruled out (Z03.7-) placental transfusion syndromes (O43.0-) Excludes : labor and delivery complicated by fetal stress (O77.-)

AHA 12:4Q:p107 – Fetus A and B same as fetus 1 and 2 Includes: The listed conditions in the fetus as a reason for hospitalization or other obstetric care to the mother, or for termination of pregnancy Code also any associated maternal condition Excludes 1: encounter for suspected maternal and fetal conditions ruled out (Z03.7-)

One of the following 7th characters is to be assigned to each code under category O35. 7th character 0 is for single gestations and multiple gestations where the fetus is unspecified. 7th characters 1 through 9 are for cases of multiple gestations to identify the fetus for which the code applies. The appropriate code from category O30, Multiple gestation, must also be assigned when assigning a code from category O35 that has a 7th character of 1 through 9. 0 Not applicable or unspecified 1 Fetus 1 2 Fetus 2 3 Fetus 3 4 Fetus 4 5 Fetus 5 9 Other fetus O35.0xx- Maternal care for (suspected) central nervous system malformation in fetus — [♀, Age/12-55] Maternal care for fetal anencephaly Maternal care for fetal hydrocephalus Maternal care for fetal spina bifida Excludes : chromosomal abnormality in fetus (O35.1)

[♀, Age/12-55] Excludes : chromosomal abnormality in fetus (O35.1)

O35.3xx- Maternal care for (suspected) damage to fetus from viral disease in mother — [♀, Age/12-55] Maternal care for damage to fetus from maternal cytomegalovirus infection Maternal care for damage to fetus from maternal rubella

O35.4xx- Maternal care for (suspected) damage to fetus from alcohol — [♀, Age/12-55] O35.5xx- Maternal care for (suspected) damage to fetus by drugs — [♀, Age/12-55] Maternal care for damage to fetus from drug addiction

I

O 9 9

One of the following 7th characters is to be assigned to each code under category O36. 7th character 0 is for single gestations and multiple gestations where the fetus is unspecified. 7th characters 1 through 9 are for cases of multiple gestations to identify the fetus for which the code applies. The appropriate code from category O30, Multiple gestation, must also be assigned when assigning a code from category O36 that has a 7th character of 1 through 9. 0 Not applicable or unspecified 1 Fetus 1 2 Fetus 2 3 Fetus 3 4 Fetus 4 5 Fetus 5 9 Other fetus O36.0- Maternal care for rhesus isoimmunization — The development of Rh-negative agglutinins in an Rh-negative mother in response to the development of Rh-positive fetal agglutinins. Maternal care for Rh incompatibility (with hydrops fetalis)

O36.01-

O35.1xx- Maternal care for (suspected) chromosomal abnormality in fetus — [♀, Age/12-55] O35.2xx- Maternal care for (suspected) hereditary disease in fetus —

O 0 0

[2017.CM]

O35.6xx- Maternal care for (suspected) damage to fetus by radiation — [♀, Age/12-55] O35.7xx- Maternal care for (suspected) damage to fetus by other medical procedures — [♀, Age/12-55]

Maternal care for damage to fetus by amniocentesis Maternal care for damage to fetus by biopsy procedures Maternal care for damage to fetus by hematological investigation Maternal care for damage to fetus by intrauterine contraceptive device Maternal care for damage to fetus by intrauterine surgery

Maternal care for anti-D [Rh] antibodies AHA 14:4Q:p17x2 – Maternal care for anti-D [RH] antibodies

O36.011- Maternal care for anti-D [Rh] antibodies, first trimester — [♀, Age/12-55] CC-0-9 O36.012- Maternal care for anti-D [Rh] antibodies, second trimester — [♀, Age/12-55] CC-0-9 O36.013- Maternal care for anti-D [Rh] antibodies, third trimester — [♀, Age/12-55] O36.019- Maternal care for anti-D [Rh] antibodies, unspecified trimester — [♀, Age/12-55] O36.09Maternal care for other rhesus isoimmunization CC-0-9 O36.091- Maternal care for other rhesus isoimmunization, first trimester — [♀, Age/12-55] CC-0-9 O36.092- Maternal care for other rhesus isoimmunization, second trimester — [♀, Age/12-55] CC-0-9 O36.093- Maternal care for other rhesus isoimmunization, third trimester — [♀, Age/12-55] O36.099- Maternal care for other rhesus isoimmunization, unspecified trimester — [♀, Age/12-55] O36.1- Maternal care for other isoimmunization — The development of CC-0-9

agglutinins due to a blood-group incompatibility. Maternal care for ABO isoimmunization

O36.11-

Maternal care for Anti-A sensitization

Maternal care for isoimmunization NOS (with hydrops fetalis)

O35.8xx- Maternal care for other (suspected) fetal abnormality and damage — [♀, Age/12-55]

O36.111- Maternal care for Anti-A sensitization, first trimester — [♀, Age/12-55] O36.112- Maternal care for Anti-A sensitization, second trimester — [♀, Age/12-55] O36.113- Maternal care for Anti-A sensitization, third trimester — [♀, Age/12-55] O36.119- Maternal care for Anti-A sensitization, unspecified trimester — [♀, Age/12-55] O36.19Maternal care for other isoimmunization

Maternal care for damage to fetus from maternal listeriosis Maternal care for damage to fetus from maternal toxoplasmosis

O35.9xx- Maternal care for (suspected) fetal abnormality and damage, unspecified — [♀, Age/12-55]

Maternal care for Anti-B sensitization

O36.191- Maternal care for other isoimmunization, first trimester — [♀, Age/12-55] O36.192- Maternal care for other isoimmunization, second trimester — [♀, Age/12-55] O36.193- Maternal care for other isoimmunization, third trimester — [♀, Age/12-55] O36.199- Maternal care for other isoimmunization, unspecified trimester — [♀, Age/12-55] Excludes 1: = NOT CODED HERE! (Do not code both)

934

Excludes : = Not Included Here